Zha Nanxi, Pike Damien, Svenningsen Sarah, Capaldi Dante P I, McCormack David G, Parraga Grace
Imaging Research Laboratories, Robarts Research Institute, 1151 Richmond Street North, London, ON N6A 5B7, Canada.
Imaging Research Laboratories, Robarts Research Institute, 1151 Richmond Street North, London, ON N6A 5B7, Canada; Department of Medical Biophysics, The University of Western Ontario, London, Canada.
Acad Radiol. 2016 Feb;23(2):176-85. doi: 10.1016/j.acra.2015.10.010. Epub 2015 Nov 18.
(3)He magnetic resonance imaging (MRI) can be used to quantify functional responses to asthma therapy and provocation. Ventilation imaging offers quantitative information beyond ventilation defects that have not yet been exploited. Therefore, our objective was to evaluate hyperpolarized (3)He MRI ventilation defect percent (VDP) and compare this and pulmonary function measurements to ventilation image texture features and their changes post-bronchodilator administration in patients with asthma.
Volunteers with a diagnosis of asthma provided written informed consent to an ethics board-approved protocol and underwent pulmonary function tests and MRI before and after salbutamol inhalation. MR images were analyzed using VDP, and their texture was evaluated via gray-level run-length matrices. These texture classifiers were compared to VDP in responders to bronchodilation based on VDP (VDP responders) and forced expiratory volume in 1 s (FEV1) (FEV1 responders).
In total, 47 patients with asthma (18 males 39 ± 13 years, FEV1 = 79 ± 21%) reported significantly improved FEV1, FEV1/forced vital capacity (FVC), residual volume (RV)/total lung capacity (TLC) (all P = .0001) and VDP (P = .01) post-salbutamol. Post-salbutamol, VDP responders and nonresponders to salbutamol were significantly different for coarse-texture features including long-run emphasis (LRE) and long-run, low gray-level emphasis (LRLGE, both P < .05) and for FEV1 responders to salbutamol, there was significantly different long-run, high gray-level emphasis (LRHGE, P = .04). There were significant relationships for VDP with LRE (R = .50, P = .0003), LRLGE (R = .34, P = .02), and LRHGE (R = .56, P = .0001). Receiver operating characteristic curves showed VDP with the strongest performance (AUC = .92), followed by coarse-texture classifier LRHGE (AUC = .83), FEV1 (AUC = .80), LRE (AUC = .66), FVC (AUC = .58), and LRLGE (AUC = .42).
In patients with asthma, differences in ventilation patchiness post-salbutamol can be quantified using coarse-texture classifiers that are significantly different in bronchodilator responders.
³He磁共振成像(MRI)可用于量化哮喘治疗和激发试验的功能反应。通气成像提供了尚未被利用的通气缺陷之外的定量信息。因此,我们的目的是评估超极化³He MRI通气缺陷百分比(VDP),并将其与肺功能测量结果与通气图像纹理特征及其在哮喘患者使用支气管扩张剂后的变化进行比较。
诊断为哮喘的志愿者签署了经伦理委员会批准的方案的书面知情同意书,并在吸入沙丁胺醇前后进行了肺功能测试和MRI检查。使用VDP分析MR图像,并通过灰度游程矩阵评估其纹理。将这些纹理分类器与基于VDP(VDP反应者)和1秒用力呼气量(FEV1)(FEV1反应者)的支气管扩张反应者的VDP进行比较。
共有47例哮喘患者(18例男性,39±13岁,FEV1 = 79±21%)报告吸入沙丁胺醇后FEV1、FEV1/用力肺活量(FVC)、残气量(RV)/肺总量(TLC)(均P = 0.0001)和VDP(P = 0.01)显著改善。吸入沙丁胺醇后,沙丁胺醇反应者和无反应者在包括长游程强调(LRE)和长游程、低灰度强调(LRLGE,均P < 0.05)等粗纹理特征方面存在显著差异,对于沙丁胺醇的FEV1反应者,长游程、高灰度强调(LRHGE,P = 0.04)存在显著差异。VDP与LRE(R = 0.50,P = 0.0003)、LRLGE(R = 0.34,P = 0.02)和LRHGE(R = 0.56,P = 0.0001)之间存在显著关系。受试者工作特征曲线显示VDP表现最强(AUC = 0.92),其次是粗纹理分类器LRHGE(AUC = 0.83)、FEV1(AUC = 0.80)、LRE(AUC = 0.66)、FVC(AUC = 0.58)和LRLGE(AUC = 0.42)。
在哮喘患者中,使用支气管扩张反应者中显著不同的粗纹理分类器可以量化吸入沙丁胺醇后通气不均匀性的差异。